Royal London Asset Management Ltd. Sells 368,376 Shares of HCA Healthcare, Inc. $HCA

Royal London Asset Management Ltd. lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 33.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 728,575 shares of the company’s stock after selling 368,376 shares during the quarter. HCA Healthcare accounts for about 0.7% of Royal London Asset Management Ltd.’s investment portfolio, making the stock its 16th largest position. Royal London Asset Management Ltd. owned 0.33% of HCA Healthcare worth $340,143,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. Brighton Jones LLC acquired a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $1,021,000. NewEdge Advisors LLC grew its position in HCA Healthcare by 11.9% during the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after acquiring an additional 409 shares during the last quarter. Sivia Capital Partners LLC raised its position in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC bought a new stake in shares of HCA Healthcare during the second quarter worth $2,073,000. Finally, Sei Investments Co. raised its holdings in shares of HCA Healthcare by 56.3% in the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after buying an additional 49,214 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Up 2.3%

Shares of HCA Healthcare stock opened at $387.25 on Friday. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The stock has a market cap of $85.91 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.20 and a beta of 1.12. The business has a fifty day simple moving average of $429.60 and a 200 day simple moving average of $473.48.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period last year, the company earned $6.45 earnings per share. The business’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s payout ratio is presently 10.73%.

Wall Street Analyst Weigh In

Several research firms have weighed in on HCA. Stephens lowered their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Mizuho raised their price target on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a report on Wednesday, February 25th. Sanford C. Bernstein reduced their price objective on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a report on Thursday, June 4th. Oppenheimer dropped their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Finally, Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Fifteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $506.14.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.